Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
BCRX —
BIOCRYST PHARMACEUTICALS INC
CUSIP: 09058V103 · Held by 3 superinvestors · Combined value: $30,237,442
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $16,604,804 | 2,128,821 | REDUCE | -11,713 |
| 2 | Ken Griffin | 0.0% | $11,795,176 | 1,512,202 | ADD | +7,720 |
| 3 | Ray Dalio | 0.0% | $1,837,462 | 235,572 | REDUCE | -175,931 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +7,720 | +0.5% |
| Jim Simons | REDUCE | -11,713 | -0.5% |
| Ray Dalio | REDUCE | -175,931 | -42.8% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +411,503 | New |
| Jim Simons | REDUCE | -386,200 | -15.3% |
| Ken Griffin | REDUCE | -1,214,150 | -44.7% |
Who Owns BCRX? Superinvestor Holdings
BIOCRYST PHARMACEUTICALS INC is held by 3 tracked superinvestors, with a combined position value of $30 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio), Ray Dalio (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 2 reduced or exited.